EVIDENCE FOR A SUSTAINED EFFECTIVENESS OF SODIUM-CHANNEL ACTIVATORS IN FAILING HUMAN MYOCARDIUM

被引:38
作者
SCHWINGER, RHG
BOHM, M
MITTMANN, C
LAROSEE, K
ERDMANN, E
机构
[1] Medizinische Klinik I der Universität München, Klinikum Großhadern, D-8000 München 70
关键词
HUMAN MYOCARDIUM; HEART FAILURE; BDF-9148; DPI-201-106; SODIUM CHANNEL ACTIVATORS; BETA-ADRENOCEPTOR; POSITIVE INOTROPIC AGENTS;
D O I
10.1016/0022-2828(91)90170-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevation of cytosolic sodium is thought to be correlated with an increase in force of contraction due to an activation of sodium-calcium exchange. We investigated the inotropic response mediated by the new sodium-channel activator BDF 9148 (0.01-100 μmol/l) on failing human myocardium. Force of contraction was studied using electrically driven human papillary muscle strips from moderately (NYHA II-III, mitral valve replacement) and terminally (NYHA IV, heart transplantation) failing hearts. We also investigated the effects in auricular trabeculae from non-failing hearts (aortocoronary bypass operation). Results were compared with inotropic responses to DPI 201-106 (DPI, 0.1-3 μmol/l), Ca2+ (1.8-15 mmol/l) and isoprenaline (0.001-1 μmol/l). Carbachol (100 μmol/l) and adenosine (1000 μmol/l) were examined in the presence of BDF 9148 and isoprenaline. Both sodium-channel activators, BDF 9148 and DPI 201-106, increased force of contraction in a dose-dependent manner in papillary muscle strips as well as in auricular trabeculae. BDF 9148 and DPI 201-106 were more effective (max. PIE NYHA II-III 1.6 ± 0.2 mN, NYHA IV 5.9 ± 0.7 mN, P<0.05) and more potent (EC50 (in μmol/l): NYHA IV 0.35, 0.19-0.66; NYHA II-III 1.85, 1.37-2.41) in terminally failing as compared to moderately failing left ventricular myocardium. Moreover, the positive inotropic effects of BDF 9148 were greater than those of DPI 201-106 in NYHA IV (max. PIE 2.7 ± 0.3 mN, P<0.05). In NYHA IV, BDF 9148 was as effective as CA2+ (max. PIE 5.1 ± 0.4 mN). In the same hearts, the positive inotropic effects of isoprenaline were reduced in NYHA IV (max. PIE 2.1 ± 0.3 mN) compared to NYHA II-III (max. PIE 3.4 ± 0.4 mN, P<0.05). Adenosine as well as carbachol did not affect the positive inotropic response of BDF 9148 or DPI 201-106 but reduced the effectiveness of isoprenaline (P<0.05). In myocardial membranes, BDF 9148 was 1000-fold less effective in competition experiments with 3H-ouabain than ouabain. We conclude that (1) sodium-channel activators may produce a significant cAMP-independent positive inotropic effect in left ventricular myocardium from failing human hearts; (2) the inotropic effect of sodium-channel activators were more potent and more effective in NYHA IV as compared to NYHA II-III. The degree of myocardial failure does not reduce the effectiveness of the sodium-channel activator BDF 9148. © 1991.
引用
收藏
页码:461 / 471
页数:11
相关论文
共 51 条
  • [1] ARMAH B I, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR50
  • [2] SODIUM-CALCIUM EXCHANGE IN HEART - MEMBRANE CURRENTS AND CHANGES IN [CA-2+]I
    BARCENASRUIZ, L
    BEUCKELMANN, DJ
    WIER, WG
    [J]. SCIENCE, 1987, 238 (4834) : 1720 - 1722
  • [3] COUPLING OF ADENOSINE RECEPTORS TO A PERTUSSIS TOXIN-SENSITIVE G-PROTEIN IN THE HUMAN-HEART
    BOHM, M
    GIERSCHIK, P
    UNGERER, M
    ERDMANN, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5): : 407 - 411
  • [4] POSITIVE INOTROPIC EFFECT OF BAY K-8644 - CAMP-INDEPENDENCE AND LACK OF INHIBITORY EFFECT OF ADENOSINE
    BOHM, M
    BURMANN, H
    MEYER, W
    NOSE, M
    SCHMITZ, W
    SCHOLZ, H
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (04) : 447 - 450
  • [5] FUNCTIONAL EVIDENCE FOR THE EXISTENCE OF ADENOSINE RECEPTORS IN THE HUMAN-HEART
    BOHM, M
    MEYER, W
    MUGGE, A
    SCHMITZ, W
    SCHOLZ, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (03) : 323 - 326
  • [6] BOHM M, 1989, BRIT J PHARMACOL, V98, P275
  • [7] BOHM M, 1988, J CARDIOVASC PHARM, V12, P726
  • [8] BOHM M, 1988, J CARDIOVASC PHARM, V11, P461
  • [9] LOCALIZATION OF A POSTRECEPTOR DEFECT IN HUMAN DILATED CARDIOMYOPATHY
    BOHM, M
    GIERSCHIK, P
    JAKOBS, KH
    SCHNABEL, P
    KEMKES, B
    ERDMANN, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (12) : 812 - 814
  • [10] INTRACELLULARLY APPLIED SODIUM MIMICS THE EFFECTS OF OUABAIN IN SINGLE CARDIAC MYOCYTES
    BORCHARD, M
    RAVENS, U
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) : 269 - 272